DOUBLE STRANDED OLIGONUCLEOTIDE COMPOUNDS COMPRISING POSITIONAL MODIFICATIONS
Disclosed herein are double stranded RNA molecules which have been modified to exhibit one of the following, increased activity, enhanced nuclease stability, reduced off target activity and or reduced immunogenicity, to pharmaceutical compositions comprising such compounds and to methods of use. Fur...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
24.09.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Disclosed herein are double stranded RNA molecules which have been modified to exhibit one of the following, increased activity, enhanced nuclease stability, reduced off target activity and or reduced immunogenicity, to pharmaceutical compositions comprising such compounds and to methods of use. Further disclosed is a method for the synthesis of threose nucleic acid phosphoramidites and methods of use thereof.
La présente invention concerne des molécules d'ARN à double brin qui ont été modifiées pour présenter une des caractéristiques suivantes : une activité accrue, une stabilité améliorée aux nucléases, une activité hors cible réduite et/ou une immunogénicité réduite. L'invention concerne également des compositions pharmaceutiques comprenant de tels composés et des procédés d'utilisation de celles-ci. L'invention concerne en outre un procédé de synthèse de phosphoramidites d'acides nucléiques à base de thréose et des procédés d'utilisation de ceux-ci. |
---|---|
AbstractList | Disclosed herein are double stranded RNA molecules which have been modified to exhibit one of the following, increased activity, enhanced nuclease stability, reduced off target activity and or reduced immunogenicity, to pharmaceutical compositions comprising such compounds and to methods of use. Further disclosed is a method for the synthesis of threose nucleic acid phosphoramidites and methods of use thereof.
La présente invention concerne des molécules d'ARN à double brin qui ont été modifiées pour présenter une des caractéristiques suivantes : une activité accrue, une stabilité améliorée aux nucléases, une activité hors cible réduite et/ou une immunogénicité réduite. L'invention concerne également des compositions pharmaceutiques comprenant de tels composés et des procédés d'utilisation de celles-ci. L'invention concerne en outre un procédé de synthèse de phosphoramidites d'acides nucléiques à base de thréose et des procédés d'utilisation de ceux-ci. |
Author | AVKIN-NACHUM, SHARON FEINSTEIN, ELENA BEIGELMAN, LEONID |
Author_xml | – fullname: BEIGELMAN, LEONID – fullname: AVKIN-NACHUM, SHARON – fullname: FEINSTEIN, ELENA |
BookMark | eNqFissKwjAQAHPQg69vMD8gaPXQa9xN60KaLU1yLkXWk6SF-v-I4t3TzMCs1SKPWVaqQU5XZ3WInfFoUbOjmn0CZzkSWg3ctJw8hq91FMjXuuVAkdgbpxtGqgjMJ8NWLR_Dc5bdjxu1r2yE20GmsZd5Gu6S5dWDKcpTeSwucP5_vAGmuy-- |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSES OLIGONUCLEOTIDIQUES A DOUBLE BRIN COMPRENANT DES MODIFICATIONS DE POSITION |
ExternalDocumentID | CA2818024C |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2818024C3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:27:31 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2818024C3 |
Notes | Application Number: CA20112818024 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190924&DB=EPODOC&CC=CA&NR=2818024C |
ParticipantIDs | epo_espacenet_CA2818024C |
PublicationCentury | 2000 |
PublicationDate | 20190924 |
PublicationDateYYYYMMDD | 2019-09-24 |
PublicationDate_xml | – month: 09 year: 2019 text: 20190924 day: 24 |
PublicationDecade | 2010 |
PublicationYear | 2019 |
RelatedCompanies | QUARK PHARMACEUTICALS, INC |
RelatedCompanies_xml | – name: QUARK PHARMACEUTICALS, INC |
Score | 3.2222579 |
Snippet | Disclosed herein are double stranded RNA molecules which have been modified to exhibit one of the following, increased activity, enhanced nuclease stability,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS SUGARS VINEGAR WINE |
Title | DOUBLE STRANDED OLIGONUCLEOTIDE COMPOUNDS COMPRISING POSITIONAL MODIFICATIONS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190924&DB=EPODOC&locale=&CC=CA&NR=2818024C |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT8IwFH5BNOpNUYO_dzC7LQrbOjgsBtoOZti6ADPcyApL9DKIzPjv-1qZeuHWtMlL-zWvr7--7wE8SOK1cG3sWu5CZpZDHM_qOh1p2W13uZQd4rXbio0cxWSYOi8zd1aDt4oLo3VCv7Q4InrUAv291Ov1-u8Si-m_lZtH-Y5Vq-dg6jNzezrG6IbnCZP1fZ4IJqhJqU97Zjz2legRhiO6B_u4ifbU5y_-2leclPX_gBKcwEGCtoryFGp50YAjWuVda8BhtH3uxuLW8zZnEDGR9kfcUDmOY8aZIUbhQMQpHXExDRk3qIgSkcZsokvjcBLGAyMRk_BH7daIBAuDijZ8DvcBn9Khhf2a_0Iwp71qAPYF1ItVkTcV3TpvLSVZuC2SOU9ZF6fDsbOOUoxHpIl9Cc1dVq52N13DsQLS0i8vN1AvPz7zWwy8pbzTmH0D5vmBWw |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT8IwFH5BNOJNUYM_2cHstihsK-OwGGg7qG7rApvhRlZYgpdBZMZ_33Yy9cKtaZOX9jWvX3993wN4EKjXkWtj37AXIjUsZPWMvuUIw-zay6VwUK_bVWzkIETjxHqZ2bMarCouTKkT-lWKI8qIWsh4L8r1evN3iUXKv5XbR_Euq9bPXuwSfXc6lugmzxM6Gbo04oRjHWMXD_Rw4irRIwlH-AAO5QbbUSr79G2oOCmb_4DincJRJG3lxRnUsrwJDVzlXWvCcbB77pbFXeRtzyEgPBn6VFM5jkNCicZ9NuJhgn3KY0aohnkQ8SQk07I0YVMWjrSIT9mP2q0WcMK8ijZ8AW2PxnhsyH7Nf10wx4NqAOYl1PN1nrUU3TrrLAVa2B2UWk9pX06HZaaOUoyXnkbmFbT2Wbne39SGxjgO_LnPwtcbOFFONcpXmFuoFx-f2Z0E4ULcl_77Bh-whEs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DOUBLE+STRANDED+OLIGONUCLEOTIDE+COMPOUNDS+COMPRISING+POSITIONAL+MODIFICATIONS&rft.inventor=BEIGELMAN%2C+LEONID&rft.inventor=AVKIN-NACHUM%2C+SHARON&rft.inventor=FEINSTEIN%2C+ELENA&rft.date=2019-09-24&rft.externalDBID=C&rft.externalDocID=CA2818024C |